title: The pH-partition profile of the anti-ischemic drug trimetazidine may explain its reduction of intracellular acidosis.
abstract: OBJECTIVE
  The anti-ischemic drug trimetazidine (TMZ) acts by a combination of molecular mechanisms which begin to be understood. Thus, it acts in the micromolar range to significantly reduce intracellular acidification during ischemia. To search for a possible physicochemical explanation of this phenomenon, we investigated the transfer mechanisms of the various electrical forms of this dibasic drug.
  
  
  METHODS
  The transfer characteristics of TMZ were studied by electrochemistry at the water/1,2-dichloroethane interface. Cyclic voltammetry was used to measure the formal transfer potentials of singly and doubly protonated forms of TMZ (noted TH+ and TH(2)2+, respectively) as a function of aqueous pH, and the partition coefficient of neutral TMZ (log P(T)) was measured by two-phase titration.
  
  
  RESULTS
  log P(T) was measured to be 1.04 +/- 0.06, and the acid-base dissociation constants in water were deduced to be pK(w)a1 = 4.54 +/- .02 and pK(w)a2 = 9.14 +/- 0.02. The partition coefficients of TH+ and TH(2)2+ were found to be respectively log P0'TH+ = -3.78 +/- 0.16 and log P0'TH(2)2+ = -9.84 +/- 0.30, which agrees well with the charge being delocalized on two nitrogen atoms in TH+. The pH-partition profile of TMZ was then established in the form of its ionic partition diagram, which showed that the affinity of the ions for the organic phase is pH-dependent and strongly increased by the interfacial potential.
  
  
  CONCLUSIONS
  This behavior suggests a physicochemical mechanism whereby efflux of protonated TMZ out of an acidified cell is facilitated, in effect exporting protons to extracellular space.
authors.affiliation: Laboratoire d'Electrochimie, Ecole Polytechnique Fédérale de Lausanne, Switzerland.
authors.forename: F
authors.initials: F
authors.lastname: Reymond
authors.forename: G
authors.initials: G
authors.lastname: Steyaert
authors.forename: P A
authors.initials: PA
authors.lastname: Carrupt
authors.forename: D
authors.initials: D
authors.lastname: Morin
authors.forename: J P
authors.initials: JP
authors.lastname: Tillement
authors.forename: H H
authors.initials: HH
authors.lastname: Girault
authors.forename: B
authors.initials: B
authors.lastname: Testa
mesh_terms: D000136:Acid-Base Equilibrium / Q000187:drug effects; D000138:Acidosis / Q000188:drug therapy*; D055598:Chemical Phenomena; D002627:Chemistry, Physical; D004553:Electric Conductivity; D004563:Electrochemistry; D006863:Hydrogen-Ion Concentration; D007511:Ischemia / Q000188:drug therapy*; D008055:Lipids / Q000737:chemistry; D011522:Protons; D012995:Solubility; D014292:Trimetazidine / Q000737:chemistry / Q000494:pharmacology*; D014665:Vasodilator Agents / Q000737:chemistry / Q000494:pharmacology*; D014867:Water / Q000737:chemistry
chemical_list: D008055:Lipids; D011522:Protons; D014665:Vasodilator Agents; D014867:Water; D014292:Trimetazidine